Stryker Corporation (SYK) Comparison with companies in other sectors?

Stryker Corporation has a share price of 382.17M. You can analyze Stryker Corporation (SYK) competitors across different market sectors through stock heatmaps.

What are SYK's NET and operating margins?

Stryker Corporation (SYK) operating margin is around 0.16, and net profit margin is approximately 0.12 as of the latest reports.

In what way does SYK's earnings per share (EPS) trend reflect its financial momentum?

Stryker Corporation (SYK) EPS is 7.40 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Stryker Corporation is 52.35, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Stryker Corporation?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Stryker Corporation like P/E which is 51.92, P/B which is 3.23, and PEG which is -11.34. Compare them with sector averages to evaluate if the stock is priced fairly.

Stryker Corporation

SYK•NYSE

Healthcare

Medical - Devices

$394.46

$5.06(1.30%)

Fundamental Analysis of Stryker Corporation (SYK)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$7.40

P/E Ratio

52.35

ROE

0.11%

Net Margin

0.12%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$148.05B

Shares OutstandingTotal number of shares issued

$382.17M

Book Value/ShareNet worth per share

$120.53

Revenue/ShareAnnual revenue per share

$60.83

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$7.4

Net MarginNet income as percentage of revenue

12.31%

Operating MarginOperating income as percentage of revenue

15.77%

ROEReturn on shareholders' equity

10.73%

ROAReturn on total assets

6.21%

ROCEReturn on capital employed

9.61%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$9.37

Cash/ShareCash and equivalents per share

$6.31

FCF YieldFree cash flow as percentage of market cap

2.41%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$3.32

Dividend YieldAnnual dividend as percentage of stock price

0.85%

Financial Ratios Analysis data is not available for SYKFinancial Ratios Analysis details for SYK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for SYKSector Benchmarking details for SYK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Stryker Corporation Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Stryker Corporation. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Stryker Corporation's unique business strengths and challenges.

Key Financial Metrics for Stryker Corporation

For Stryker Corporation, essential financial indicators include EPS 7.40, PE 52.35, and ROE 0.11. These key ratios reveal insights into Stryker Corporation's profitability, valuation, and operational health. Understanding these metrics enables you to compare Stryker Corporation with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Stryker Corporation

Metrics like Net Margin 12.31% and ROA 6.21% shed light on how well Stryker Corporation is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Stryker Corporation can sustain its operations and continue growing in the future.

Valuation and Market Position of Stryker Corporation

Using ratios such as P/B Ratio 3.23 and PEG Ratio -11.34, investors can assess whether Stryker Corporation is appropriately valued based on its financials and growth potential. These figures, combined with Stryker Corporation's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Stryker Corporation

Financial health indicators, such as Debt/Equity Ratio 0.31 and Cash Flow $9.37, provide a snapshot of Stryker Corporation's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Stryker Corporation, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Stryker Corporation

Investing in Stryker Corporation based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Stryker Corporation focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;